Donor type, in Addition to Transplantation in Chronic Phase and Myeloablative Conditioning, Influence Transplant Survival for Patients with Advanced Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors

Na minha lista:
Detalhes bibliográficos
Publicado no:Leukemia
Main Authors: Kongtim, Piyanuch, Adekola, Kehinde, Milton, Denái R., Ramlal, Reshma, Jimenez, Antonio, Chen, Julianne, Rondon, Gabriela, Ahmed, Sairah, Kebriaei, Partow, Betul, Oran, Hosing, Chitra M., Popat, Uday, Khouri, Issa, Jabbour, Elias, Cortes, Jorge E., Kantarjian, Hagop M., Champlin, Richard E., Ciurea, Stefan O.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6192023/
https://ncbi.nlm.nih.gov/pubmed/28400618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2017.118
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados